Detalhe da pesquisa
1.
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications.
Int J Tuberc Lung Dis
; 27(6): 451-457, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37231598
2.
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
Trials
; 24(1): 773, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38037119
3.
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.
Trials
; 22(1): 651, 2021 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563240
4.
TB research requires strong protections, innovation, and increased funding in response to COVID-19.
Trials
; 22(1): 371, 2021 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051826